Predictors of EGFR mutation and factors associated with clinical tumor stage at diagnosis: Experience of the INSIGHT study in Poland.

@article{Ramlau2017PredictorsOE,
  title={Predictors of EGFR mutation and factors associated with clinical tumor stage at diagnosis: Experience of the INSIGHT study in Poland.},
  author={Rodryg Adam Ramlau and Paweł Adam Krawczyk and Rafal Dziadziuszko and Izabela Chmielewska and J Anusz Milanowski and Włodzimierz T. Olszewski and Katarzyna Stencel and Katarzyna Ramlau-Piątek and Agnieszka Segiet and Michał K. Skroński and Jacek Grudny and Joanna Chorostowska-Wynimko},
  journal={Oncology letters},
  year={2017},
  volume={14 5},
  pages={
          5611-5618
        }
}
Targeted therapy of non-small cell lung cancer (NSCLC) patients with mutations in the epidermal growth factor receptor (EGFR) gene has been associated with improved prognosis. However, there is a shortage on data from real-world clinical practice in management of EGFR-positive NSCLC patients in Poland. The present study retrospectively analyzed data from the INSIGHT study to evaluate the incidence and clinical management of EGFR-positive NSCLC in Poland. The authors additionally aimed to… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 45 REFERENCES

Epidermal growth factor receptor mutation - positive non - small - cell lung cancer in the real - world setting in central Europe : The INSIGHT Study

  • MM Oken, RH Creech, +4 authors PP Carbone
  • J Thorac Oncol
  • 2015

Similar Papers

Loading similar papers…